Hungarian hospital starts a clinical trial of long term effect of trimodal prehabilitation compared to ERAS in colorectal cancer surgery
Photo by Jennifer Latuperisa-Andresen
St. Borbala Hospital in collaboration with Biological Research Centre (Szeged, Hungary) is enrolling patients into the clinical trial investigating the long term effect of trimodal prehabilitation compared to ERAS in colorectal cancer surgery (Prehab_2).
The hospital is recruiting patients in the following locations Department of Surgery, St. Borbala Hospital (Tatabánya, Hungary, 2800) and St. Borbala Hospital (Tatabánya, Hungary, 2800).
Elective surgery is the most effective treatment option for colorectal cancer, however it has been recognized to be associated with high morbidity and mortality risks.
ERAS (Enhanced Recovery After Surgery) is a preoperative multimodality treatment package, which has been well investigated and proved to be effective in reducing early postoperative morbidity, mortality, length of hospital stay and hospital costs, as well. Still, a good proportion of patients are not suitable for ERAS program, mainly based on lack of compliance and the impaired physical function before surgery.
Trimodal Prehabilitation Program is a recently introduced preoperative preparation (training) program, which addresses improvement of physical, mental and nutritional status of the high risk elective surgery patients.
The focus of a clinical study are
Procedure: Trimodal rehabilitation + ERAS (Prehabilitation will cover a range preoperative education and exercises (weekly) on diet, physical activity (daily walking), respiratory training (forced deep inspiration with spirometer device), as well as anxiolytic group psychotherapy.)
Procedure: ERAS + nutritional prehabilitation (Enhanced Recovery Program, including preoperative 4 weeks nutritional supplementation.)
This study aims to investigate the benefit of all efforts of a 4-6-week preoperative preparation program (Prehabilitation) being added to an established ERAS protocol.
Additionally the effect of trimodal prehabilitation on gut microbiom diversity and its relation to clinical outcome will be analyzed.
On 7 September, first participant was enrolled into this clinical study. The estimated study completion date is September 7, 2030.
The population that are excluded from participation:
- emergency operation;
- palliative operation;
- non-colorectal, second malignancy;
- patient not giving consent
This page provides a more detailed overview of this clinical trial: https://ichgcp.net/clinical-trials-registry/NCT04595604
Clinical Research News
Upcoming Clinical Trials
NCT04641585Not yet recruitingConditions: Brugada Syndrome 1
NCT04641611Not yet recruitingEffect of Venous Cannulation on the Incidence of Atrial Fibrillation in Patients Undergoing Coronary Artery BypassConditions: Atrial Fibrillation
NCT04641637Not yet recruitingBalloon Assisted Transarterial Therapy for HCC: a Study on the Proof of Treatment Concept and Exploration of Selection Criteria for Clinical ApplicationConditions: to Prove the Treatment Concept of the Use of Balloon Assistance in Transarterial Therapy for HCC
NCT04641650Not yet recruitingContinuous Monitoring of Glucose With a FreeStyle Libre Pro Sensor in Diabetic and Dialysis PatientsConditions: Kidney Failure; Diabetes
NCT04641663Not yet recruitingConditions: Aging; Age-related Cognitive Decline
NCT04641702Not yet recruitingConditions: Achalasia
NCT04641728Not yet recruitingConditions: Cervical Cancer
NCT04641741Not yet recruitingConditions: Asthma; Eosinophilic
NCT04641806Not yet recruitingConditions: B-cell Lymphoma; Covid19
NCT04641819Not yet recruitingConditions: Carcinoma; Sleep Disorder
Recent CRA jobs
Sr CRA (Level II) Sofia, Bulgaria
Site Contract Specialist
Senior Systems Specialist - R, SQL
Country Approval Specialist (Belgrade, Serbia)
Group Leader - Immunochemistry R&D
(Senior) Clinical Research Associate
Associate Group Leader– Cell and Molecular Biology Lab - Athlone, Ireland – Joining Bonus €3000
(Sr) Project Mgr - Early Development Services (Ph I Trials)
CRA (Level II) - Mexico
Associate Scientist / Scientist - QC Technician - GMP ( 3rd Shift )